Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 18 Similar Profiles
T-Lymphocytes Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences
Antigens Medicine & Life Sciences
Fibroblasts Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Cytokines Medicine & Life Sciences
Experimental Arthritis Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1987 2024

Research Output 1975 2017

1 Citations

CD6 as a potential target for treating multiple sclerosis

Li, Y., Singer, N. G., Whitbred, J., Bowen, M. A., Fox, D. A. & Lin, F. Mar 7 2017 In : Proceedings of the National Academy of Sciences of the United States of America. 114, 10, p. 2687-2692 6 p.

Research output: Contribution to journalArticle

Multiple Sclerosis
Autoimmune Experimental Encephalomyelitis
Cell Survival
Spinal Cord
2 Citations

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis

Mor-Vaknin, N., Saha, A., Legendre, M., Carmona-Rivera, C., Amin, M. A., Rabquer, B. J., Gonzales-Hernandez, M. J., Jorns, J., Mohan, S., Yalavarthi, S., Pai, D. A., Angevine, K., Almburg, S. J., Knight, J. S., Adams, B. S., Koch, A. E., Fox, D. A., Engelke, D. R., Kaplan, M. J. & Markovitz, D. M. Feb 6 2017 In : Nature Communications. 8, 14252

Research output: Contribution to journalArticle

Nucleotide Aptamers
Supravalvular Aortic Stenosis

Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma

Hutchings, K. M., Lisabeth, E. M., Rajeswaran, W., Wilson, M. W., Sorenson, R. J., Campbell, P. L., Ruth, J. H., Amin, A., Tsou, P. S., Leipprandt, J. R., Olson, S. R., Wen, B., Zhao, T., Sun, D., Khanna, D., Fox, D. A., Neubig, R. R. & Larsen, S. D. Apr 15 2017 In : Bioorganic and Medicinal Chemistry Letters. 27, 8, p. 1744-1749 6 p.

Research output: Contribution to journalArticle

Systemic Scleroderma
Pharmaceutical Chemistry
2 Citations
Lysosphingolipid Receptors
Autoimmune Diseases
Multiple Sclerosis
Autoimmune Diseases of the Nervous System
Chronic Progressive Multiple Sclerosis

TLRs, future potential therapeutic targets for RA

Elshabrawy, H. A., Essani, A. E., Szekanecz, Z., Fox, D. A. & Shahrara, S. Feb 1 2017 In : Autoimmunity Reviews. 16, 2, p. 103-113 11 p.

Research output: Contribution to journalReview article

Rheumatoid Arthritis
Toll-Like Receptors
Myeloid Cells